Header Logo

Connection

John Somberg to Arrhythmias, Cardiac

Back to Details
This is a "connection" page, showing publications John Somberg has written about Arrhythmias, Cardiac.
John Somberg
Connection Strength
3.121
Arrhythmias, Cardiac
  1. Ventricular repolarization spectra. Cardiology. 2008; 111(3):207-8.
    View in: PubMed
    Score: 0.284
  2. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther. 2005 Jul-Aug; 12(4):328-36.
    View in: PubMed
    Score: 0.233
  3. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias. Am J Ther. 2005 May-Jun; 12(3):218-22.
    View in: PubMed
    Score: 0.231
  4. Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol. 2002 Nov 15; 90(10):1103-6.
    View in: PubMed
    Score: 0.194
  5. Arrhythmia therapy. Am J Ther. 2002 Nov-Dec; 9(6):537-42.
    View in: PubMed
    Score: 0.194
  6. Usefulness of QT dispersion as an electrocardiographically derived index. Am J Cardiol. 2002 Feb 01; 89(3):291-4.
    View in: PubMed
    Score: 0.184
  7. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001 Mar-Apr; 8(2):117-22.
    View in: PubMed
    Score: 0.173
  8. Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation. Pediatr Cardiol. 2020 Feb; 41(2):418-422.
    View in: PubMed
    Score: 0.157
  9. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. Am J Ther. 1997 Nov-Dec; 4(11-12):401-4.
    View in: PubMed
    Score: 0.137
  10. Successful heart failure therapy is effective antiarrhythmia therapy. Am Heart J. 1996 May; 131(5):1048-50.
    View in: PubMed
    Score: 0.124
  11. Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J. 1994 Sep; 128(3):575-85.
    View in: PubMed
    Score: 0.110
  12. Amiodarone therapy guided by electrophysiologic testing: an update. J Clin Pharmacol. 1991 Nov; 31(11):1089-95.
    View in: PubMed
    Score: 0.090
  13. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25.
    View in: PubMed
    Score: 0.083
  14. The role of electrophysiologic testing in the selection of amiodarone therapy. J Clin Pharmacol. 1989 May; 29(5):429-35.
    View in: PubMed
    Score: 0.076
  15. The effects of chiral isolates of methadone on the cardiac potassium channel IKr. Cardiology. 2009; 113(1):59-65.
    View in: PubMed
    Score: 0.074
  16. Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72.
    View in: PubMed
    Score: 0.068
  17. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76.
    View in: PubMed
    Score: 0.062
  18. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8.
    View in: PubMed
    Score: 0.061
  19. Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53.
    View in: PubMed
    Score: 0.061
  20. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7.
    View in: PubMed
    Score: 0.060
  21. The arrhythmogenicity of antiarrhythmic agents. Am Heart J. 1985 May; 109(5 Pt 1):1090-7.
    View in: PubMed
    Score: 0.058
  22. Prolonged repolarization: a historical perspective. Am Heart J. 1985 Feb; 109(2):395-8.
    View in: PubMed
    Score: 0.057
  23. Antiarrhythmic drug therapy. Recent advances and current status. Cardiology. 1985; 72(5-6):329-48.
    View in: PubMed
    Score: 0.056
  24. New approaches to drug selection and serial drug testing. J Clin Pharmacol. 1984 Jul; 24(7):320-7.
    View in: PubMed
    Score: 0.054
  25. Flecainide toxicity. Am J Cardiol. 1984 Jan 15; 53(2):329-30.
    View in: PubMed
    Score: 0.053
  26. Lithium, hypercalcemia, and arrhythmia. J Clin Psychopharmacol. 1998 Oct; 18(5):420-3.
    View in: PubMed
    Score: 0.037
  27. Proarrhythmia of nonantiarrhythmic drugs. Am Heart J. 1993 Jul; 126(1):201-5.
    View in: PubMed
    Score: 0.025
  28. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 1991 Nov; 31(11):1061-9.
    View in: PubMed
    Score: 0.023
  29. Encainide: a new and potent antiarrhythmic. Am Heart J. 1987 Oct; 114(4 Pt 1):826-35.
    View in: PubMed
    Score: 0.017
  30. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16.
    View in: PubMed
    Score: 0.015
  31. Pharmacokinetics of oral cibenzoline in arrhythmia patients. Clin Pharmacokinet. 1985 Mar-Apr; 10(2):178-86.
    View in: PubMed
    Score: 0.014
  32. Cibenzoline plasma concentration and antiarrhythmic effect. Clin Pharmacol Ther. 1984 Mar; 35(3):307-16.
    View in: PubMed
    Score: 0.013
  33. Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther. 1980 Aug; 214(2):375-80.
    View in: PubMed
    Score: 0.010
  34. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Eur J Pharmacol. 1979 Feb 15; 54(1-2):161-6.
    View in: PubMed
    Score: 0.009
  35. Role of the nervous system in the genesis of cardiac rhythm disorders. Am J Cardiol. 1976 Jun; 37(7):1111-3.
    View in: PubMed
    Score: 0.008
  36. Neural basis for the genesis and control of digitalis arrhythmias. Cardiology. 1976; 61(1):50-60.
    View in: PubMed
    Score: 0.008
  37. The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther. 1974 Feb; 207(2):340-7.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.